Other Deals

JB Pharma buys licences, distribution rights of Novartis eye care portfolio in India for Rs.1,089-Cr

Economic Times  

JB Chemicals & Pharmaceuticals (JB Pharma) has entered into trademark licensing agreement along with distribution and promotion of a portfolio of select ophthalmology brands of Novartis for a total consideration of INR 1,089 crore in an all cash deal.

Want to receive such news items in your inbox? Click Here to sign up for a trial.

2021 © TSJ Media Pvt Ltd. All rights reserved.